Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Thiel-backed Lindus sells CRO arm in pivot to hunt for drug assets

A Peter Thiel-backed transatlantic startup that once branded itself as an “anti-CRO” is pivoting from a clinical trials operator to a drug developer. Lindus Therapeutics is betting that its experience over ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Friday 4 September →